Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Accumulated Depreciation: 2024

Historic Accumulated Depreciation for CG Oncology (CGON) over the last 1 years, with Dec 2024 value amounting to $87,000.

  • CG Oncology's Accumulated Depreciation was N/A to $623,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $623,000, marking a year-over-year change of. This contributed to the annual value of $87,000 for FY2024, which is N/A change from last year.
  • CG Oncology's Accumulated Depreciation amounted to $87,000 in FY2024.
  • Over the past 5 years, CG Oncology's Accumulated Depreciation peaked at $87,000 during FY2024, and registered a low of $87,000 during FY2024.
  • Its 1-year average for Accumulated Depreciation is $87,000, with a median of $87,000 in 2024.